The Effects of Short Message Notifications on Middle-Aged Diabetic Patients

Istanbul University

Status

Completed

Conditions

Type2 Diabetes Mellitus

Treatments

Other: Informative messages

Study type

Interventional

Funder types

Other

Identifiers

NCT04733612

20135

Details and patient eligibility

About

The objective of our study was to assess awareness-raising of medication adherence (MA), physical activity (PA), fasting blood glucose (FBG), and glycated hemoglobin A (HbA1c) values by providing information on diabetes via short message (SMS) technology.

Full description

The study investigates T2DM patients who have not had surgery or cardiac event in the last 3 months, between the ages of 40 and 64 years, with T2DM diagnosis between the last 1 and 10 years and oral antidiabetic therapy for at least 1 The study design is a single-blinded randomized, controlled study, and was conducted in the Diabetes Polyclinic of the Istanbul University Medical Faculty Hospital.

Patients randomly assigned to the intervention group, in addition to traditional treatment received three to four informative SMS messages per week during the 6-month period, while the control group was followed in accordance with the traditional treatment schedule.

Enrollment

125 patients

Sex

All

Ages

40 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Clinical diagnosis of Type 2 Diabetes Mellitus (T2DM) between the last 1 and 10 years
Being aged between 40 and 64 years old,
Is treated for a minimum of 1 year with at least one oral antidiabetic drug.

Exclusion criteria

Clinical diagnosis of T2DM for less than 1 year or more than 10 years.
Those who have had surgery or a cardiac event in the last 3 months or during the investigation.
Those under 40 and over 64 years of age.
Patients with T2DM that have not been treated with oral antidiabetic medication.
Volunteers who once did not participate in the control examinations in both groups were excluded from the evaluation.